Should preclinical studies be registered?

From National Research Council Canada

  1. (PDF, 36 KB)
DOIResolve DOI:
AuthorSearch for: ; Search for:
PubMed Central IDPMC4516408
Funding Reference Number102823-1
PubMed ID22678379
CAMS IDcams4748
Copyright statementSee terms of use in CIHR Copyright and Disclaimer Notices.
Journal titleNature biotechnology
Publication date
  1. Clinical trial registration: looking back and moving ahead
  2. Shining a light on trial data
  3. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
  4. Can the pharmaceutical industry reduce attrition rates?
  5. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis
  6. Neutralization of tumor necrosis factor in preclinical models of sepsis
  7. Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?
  8. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data
  9. Publication of NIH funded trials registered in cross sectional analysis
  10. Issues in the registration of clinical trials
Export citationExport as RIS
CollectionCanadian Institutes of Health Research 2009–2017
Record identifier1072dc29-2173-4e14-acfe-faf2191aa57b
Record created2018-04-26
Record modified2018-04-26
Date modified: